{"id":"NCT01807650","sponsor":"Birken AG","briefTitle":"Oleogel-S10 in Wound Healing of Split-Thickness Skin Graft Donor Sites (BSG-12)","officialTitle":"Open, Blindly Evaluated, Prospective, Controlled, Randomized, Multicenter Phase III Clinical Trial to Compare Intra-individually the Efficacy and Tolerance of Oleogel-S10 Versus Standard of Care in Accelerating the Wound Healing of Split-Thickness Skin Graft Donor Sites","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2013-03","primaryCompletion":"2013-09","completion":"2014-09","firstPosted":"2013-03-08","resultsPosted":"2018-07-19","lastUpdate":"2018-07-19"},"enrollment":112,"design":{"allocation":"RANDOMIZED","model":"SINGLE_GROUP","masking":"SINGLE","primaryPurpose":"TREATMENT"},"conditions":["Wounds"],"interventions":[{"type":"DRUG","name":"Oleogel-S10, non-adhesive wound dressing","otherNames":["Episalvan®"]},{"type":"DEVICE","name":"Non-adhesive wound dressing only","otherNames":["Mepilex®"]}],"arms":[{"label":"Oleogel-S10, non-adhesive wound dressing","type":"EXPERIMENTAL"},{"label":"Non-adhesive wound dressing only","type":"OTHER"}],"summary":"The main purpose of this phase III clinical trial was to show safety and efficacy of Oleogel-S10 in accelerating the wound healing of Split-Thickness Skin Graft (STSG) donor sites.","primaryOutcome":{"measure":"Intra-individual Difference in Time to Wound Closure","timeFrame":"2 to 4 weeks","effectByArm":[{"arm":"Entire Study Population","deltaMin":-0.8,"sd":null}],"pValues":[{"comp":"OG000","p":"=0.0232"}]},"eligibility":{"minAge":"18 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":5,"exclusionCount":10},"locations":{"siteCount":14,"countries":["France","Greece","Latvia","Spain"]},"refs":{"pmids":["28400148"],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":4,"n":112},"commonTop":["Pyrexia","Pain of skin","Skin infection","Pruritus","Constipation"]}}